Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI-SOCIME 2022 | Mitral valve replacement

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Ignacio Amat Santos, entitled “Mitral valve replacement”

amat-santos-tmvr


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-SOCIME 2022 | Big Necks, (PEVAR IN HOSTILE NECK) – Dr. Juan Varela

Veja esta apresentação do Dr. Juan Varela (COL) durante o Congresso SOLACI-SOCIME 2022 realizado na Expo Santa Fé, CDMX nos dias 4, 5 e...

SOLACI-SOCIME 2022 | Advances in the design of STENTS in PCI: DIABETES MELLITUS – Dr. Roxana Mehran

Enjoy this master conference given by Dr. Roxana Mehran during the SOLACI-SOCIME 2022 Congress held at Expo Santa Fé, CDMX on August 4, 5...

SOLACI-SOCIME 2022 | Management of entrapped equipment, by Dr. José Velazco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. José Velazco, entitled...

SOLACI-SOCIME 2022 | Transcatheter treatment of mitral valve regurgitation, by Dr. Luis Nombela Franco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Luis Nombela Franco,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...